Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus placebo for vascular hemodynamics in adults with type 2 diabetes
2008-000815-13Phase 3Terminated
- Sponsor
- Technical University of Munich
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Technical University of Munich. Primary endpoint: Change in cerebral vasomotor reactivity. Started Apr 2008; status: terminated.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-000815-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000815-13.